Medication Guide App

Clinical Trials Update: June 3, 2009

-- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Constipation

If you have constipation from taking opioid pain medication, you may qualify for this study.

The research site is in Edina, Minn.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=247.

-----

Epilepsy

If you are at least 16 with epilepsy and have a history of inadequate response to treatment with at least one anti-epileptic drug, you may qualify for this study.

The research site is in Tucson, Ariz.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=62.

-----

Crohn's Disease

If you are an adult with moderate-to-severe active confirmed Crohn's disease of at least three months' duration, you may qualify for this study.

The research site is in Bellevue, Wash.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=51.

-----

High Blood Pressure (Hypertension)

This study is enrolling people with high blood pressure.

The research sites are located throughout the United States.

More information

Please see http://www.clinicalconnection.com/5485.aspx.

-----

Coronary Artery Disease

This study will evaluate an investigational medication for coronary heart disease.

The research site is in Miami, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/heart_disease.aspx.

-----

Rheumatoid Arthritis

This study is evaluating the effectiveness of an investigational medication for rheumatoid arthritis (RA). Participants must be at least 18, diagnosed with RA for at least six months, and have active symptoms.

The research site is in Sarasota, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/rheumatoid_arthritis.aspx.

-----

Copyright 2009 CenterWatch and ClinicalConnection.com. All rights reserved.

Posted: June 2009


View comments

Hide
(web5)